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Abstract: With the technological advances of the last decade, it is now feasible to analyze microbiome
samples, such as human stool specimens, using multi-omic techniques. Given the inherent sample
complexity, there exists a need for sample methods which preserve as much information as possible
about the biological system at the time of sampling. Here, we analyzed human stool samples
preserved and stored using different methods, applying metagenomics as well as metaproteomics.
Our results demonstrate that sample preservation and storage have a significant effect on the taxonomic
composition of identified proteins. The overall identification rates, as well as the proportion of
proteins from Actinobacteria were much higher when samples were flash frozen. Preservation in
RNAlater overall led to fewer protein identifications and a considerable increase in the share of
Bacteroidetes, as well as Proteobacteria. Additionally, a decrease in the share of metabolism-related
proteins and an increase of the relative amount of proteins involved in the processing of genetic
information was observed for RNAlater-stored samples. This suggests that great care should be
taken in choosing methods for the preservation and storage of microbiome samples, as well as in
comparing the results of analyses using different sampling and storage methods. Flash freezing and
subsequent storage at −80 ◦C should be chosen wherever possible.
Keywords: proteomics; metaproteomics; metagenomics; microbiome; microbiota; flash freezing;
RNAlater; sample storage
1. Introduction
Humans, as well as almost all multicellular organisms are not simply the sum of their respective
cells, organs, and tissues, but an intimate and complex association of their own elements with many
different microorganisms [1–3]. If microbial partners are lost or the composition of the microbiota
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is altered, phenotypical changes may lead to health defects [4,5]. Of the different habitats that
parts of the host’s body provide, the digestive tract’s microbiome plays a central role. In mammals,
the gut microbiota possesses the highest biomass [6] and arguably has the strongest impact on the
host [7–9]. It profoundly influences the availability and composition of nutrients [10–12], susceptibility
to disease [13–15], proper ontogenesis, host behavior [7,16,17], as well as the immune system [18–21].
In consequence, there has been great interest in understanding the nature of host–microbiota
relations and elucidating the identity and role of the different members within the gut microbiota in
recent years. This promises to generate profound new insights, not only in the context of human health,
but also several technical applications, such as waste water treatment [22] and biogas production [23,24].
Furthermore, it could help to explain fundamental questions regarding interactions among uni- and
multicellular organisms.
Analyzing samples as complex as human stool constitutes a considerable challenge as they contain
vast amounts of highly diverse organisms, some of them adapted to very specific ecological niches [25].
Hence, preserving the information contained in a sample at the time of sampling is essential to
permit the inference of biological meaning. In particular, the processing of samples after collection,
as well as the subsequent storage conditions may have a profound effect on all downstream stages.
Therefore, understanding the effects of different treatments is of immediate interest, especially as
different institutions and laboratories handle sample processing in their own ways, possibly already
introducing individual biases through, for example, different storage conditions.
So far, the most widely used approaches for microbiome research are metagenomics and
metatranscriptomics, for the identification of taxa and the description of their activity [26,27].
However, as technology advances, “integrated multi-omics” approaches, which also include
metabolomics and proteomics, will surely become a widely used approach in the near future. They will
provide significantly more information, which will help our understanding of the complex network of
microbial interactions, as well as its interactions with the host [28,29].
Proteomics provides the most immediate evidence for a member of a system to be active, since
proteins are the central facilitators of all biological processes and constitute the enzymes which catalyze
metabolic reactions [30]. It might be insufficient to rely on transcriptome data alone to infer activity of
members of the microbiome, as transcript levels do not necessarily correlate with protein levels [31,32].
Additionally, vital information about the function and regulation of proteins is available through
analysis of post-translational modifications [33].
This study investigated the influence of two popular sample storage methods on protein
identification rates in a mass spectrometry-based metaproteomics study of human faecal samples and
subsequent information gain. Flash freezing of samples and subsequent storage at −80 ◦C is proven to
be the storage method that keeps samples close to their original state after specimen collection [34,35].
Furthermore, RNAlater is a popular RNA stabilizing agent [36–40] that is also often used when other
biomolecules in addition to RNA are extracted from the same sample [41,42].
The results showed a strong bias introduced by the choice of storage and processing condition on
the taxonomic origin of the identified proteins.
2. Materials and Methods
2.1. Ethics
Written informed consent was obtained from all subjects enrolled in the study. This study was
approved by the Comité d’Ethique de Recherche (CNER; reference no. 201110/05, 17 October 2011)
and the National Commission for Data Protection in Luxembourg.
2.2. Sample Collection and Processing
The stool samples were collected in Med Auxil stool collectors (Süsse GmbH & Co. KG, Gudensberg,
Germany), homogenized, and aliquoted for the different storage conditions. Aliquots for the flash
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freezing processing were transferred to 50 mL falcon tubes, flash frozen in liquid nitrogen, and stored
at −80 ◦C. After cryomilling, aliquots of 150 mg were created. To preserve RNA integrity prior to
biomolecule extraction, 1.5 mL Ambion RNAlaterICE (Thermo Fisher Scientific Inc., Waltham, MA,
USA) was added to frozen aliquots, and they were incubated for 16 h [43]. After homogenization and
lysis, extraction was performed using the AllPrep DNA/RNA/Protein Kit (Qiagen, Venlo, Netherlands)
with an in-house built automated sample preparation platform. For detailed information, see the parts
concerning the processing of human faecal samples in chapter eleven of volume 531 of Methods in
Enzymology [44].
For the RNAlater storage conditions, 200 mg aliquots of the same stool sample were stored in
1.5 mL Ambion RNAlater (Thermo Fisher Scientific Inc., Waltham, MA, USA) at 4 ◦C for 6 h, and after
that stored at −80 ◦C. Samples were thawed on ice prior to homogenization, lysis and biomolecule
extraction using the AllPrep DNA/RNA/Protein Kit (Qiagen, Venlo, Netherlands) with an in-house
built automated sample preparation platform. For detailed information, see the parts concerning the
processing of human faecal samples in chapter eleven of Volume 531 of Methods in Enzymology [44].
2.3. Metagenomics and Metatranscriptomics
DNA was treated with RNase, and RNA with DNase, before libraries were prepared
for metagenomic and metatranscriptomic sequencing, respectively. Library preparation for
metatranscriptomic sequencing, which was only successful for the flash frozen subsamples, included
the depletion of ribosomal RNAs. Libraries were prepared using a dual barcoding system and
sequenced at 150 bp paired-end on Illumina HiSeq 4000 (Illumina, Inc., San Diego, CA, USA) and
Illumina NextSeq 500 (Illumina, Inc., San Diego, CA, USA) machines at the European Molecular
Biology Laboratory (EMBL). Metagenomic and metatranscriptomic sequencing data, depleted of host
sequencing data, is accessible as SAMN12288743 and SAMN12288744 in the NCBI short read archive
under BioProject PRJNA289586. To avoid biases due to different search databases in the comparison
of metaproteomics data from different storage conditions, metagenomic reads of all samples of the
same donor were processed and de-novo assembled together with the metatranscriptomic reads of the
flash frozen subsamples, using the Integrated Meta-omic Pipeline (IMP) [45]. On top of the published
IMP workflow, metagenome-assembled genomes were generated and phylogenetically annotated with
metagenomic operational taxonomic units (mOTUs; [46]) as described in [43]. In addition, further
(incomplete) open reading frames were predicted using Prodigal [47]. Open reading frames were
prepared as metaproteomics search database by removing nontryptic peptides from the beginning
and/or ends of the predicted sequences if the start and/or stop codons, respectively, were missing.
Entries were filtered to contain only predicted sequences with at least two tryptic peptides. In addition,
human protein sequences (based on HG38) were added to the search database.
2.4. Prefractionation and Digestion
Of the protein solutions, 27 µL were separated on precast 12% Criterion XT Bis−Tris gels (Biorad,
Hercules, CA, USA). In-gel digestion was done according to Bonn et al. [48]. Sample gel lanes
were cut into ten pieces, proteins digested in-gel with trypsin, and after elution from gel, desalting
was performed with ZipTip-tips (Merck Chemicals GmbH, Darmstadt, Germany), according to
manufacturer’s instructions. After drying samples at 30 ◦C in a vacuum centrifuge, peptides were
resuspended in 10 µL 0.1% acetic acid in H2O and transferred to glass vials.
2.5. High-Pressure Liquid Chromatography and Mass Spectrometry
Of the samples, 8 µL each were loaded onto in-house built columns (100 µm × 20 cm), filled with
3 µm ReproSil-Pur material (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany), and separated
using a nonlinear 80 min gradient from 1% to 99% buffer B (99.9% acetonitrile, 0.1% acetic acid in H2O)
at a flow rate of 300 nL/min, operated on an EASY-nLC II (Thermo Fisher Scientific Inc., Waltham,
MA, USA).
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Measurement was done with an LTQ Orbitrap Velos Pro mass spectrometer (Thermo Fisher
Scientific Inc., Bremen, Germany), performing one full scan in a range from 300 to 2000 m/z, followed
by a data-dependent MS/MS scan of the 20 most intense ions, a dynamic exclusion repeat count of 1,
and repeat exclusion duration of 30 s.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium [49] via the PRIDE) partner repository [50] and is accessible using the dataset
identifier PXD014482.
2.6. Database Searching
Tandem mass spectra were extracted, and charge state deconvoluted by msConvert
(version 3.0.18188, ProteoWizard, Palo Alto, CA, USA) [51]. The 200 most intense peaks for each
spectrum were selected, and data from all fractions merged into one mgf file for each sample.
All MS/MS samples were analyzed using Mascot (version 2.6.2, Matrix Science, London, UK) [52],
Sequest (version v.27, rev. 11, Thermo Fisher Scientific, Waltham, MA, USA) [53] and X! Tandem
(version X! Tandem Vengeance (2015.12.15.2), The Global Proteome Machine Organization) [54].
Mascot, Sequest, and X! Tandem were set up to search a sample-specific database containing common
contaminants (901940 entries), assuming trypsin digestion. Mascot and X! Tandem were searched with
a fragment ion mass tolerance of 0.5 Da and a parent ion tolerance of 10 ppm. Sequest was searched
with a fragment ion mass tolerance of 1.0 Da and a parent ion tolerance of 10 ppm. Formation of
pyroglutamate from a glutamate or glutamine of the n-terminus, ammonia loss of the n-terminus,
and oxidation of methionine were specified in X! Tandem as variable modifications. Oxidation of
methionine was specified in Mascot and Sequest as a variable modification.
2.7. Criteria for Protein Identification
Scaffold (Proteome Software Inc., Portland, ME, USA; version 4.8.8) [55] was used to validate
MS/MS-based peptide and protein identifications. Scaffold combines the scores of each search engine,
as described by Searle et al. [56]. Peptide identifications were accepted if they could be established at
greater than 99% probability by the Scaffold Local False Discovery Rate (FDR) algorithm. Proteins
were filtered to a 1% FDR, requiring at least two identified proteins. Proteins that contained similar
peptides and could not be differentiated on the basis of MS/MS analysis alone were grouped to satisfy
the principles of parsimony. Proteins sharing significant peptide evidence were grouped into clusters.
2.8. Further Analyses
Significance testing was performed in Scaffold using a Benjamini–Hochberg-corrected t-test with
a significance level of 0.05. Further, a fold change of at least 1.5 was required for a protein(-group)
being significantly altered in abundance.
Functional and taxonomic annotation of identified bacterial proteins was conducted with
donor-specific metagenome-based annotations (Table S1) as well as Prophane (https://gitlab.com/s.
fuchs/prophane) [57]. Figures were created using the Matplotlib python library [58].
3. Results
To elucidate possible effects of initial sample storage on the human stool samples, metagenomics
and metaproteomics analyses were performed. Of the same stool sample three aliquots were processed,
each with the flash freezing or RNAlater refrigeration approach.
The results revealed significant differences in information content between flash frozen (FF) and
RNAlater (RL)-treated samples. As of now, the term protein(s) will be used synonymously with protein
groups as defined by the Scaffold cluster grouping method, unless explicitly stated otherwise.
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3.1. Flash Frozen Samples Achieved a Higher Protein Identification Rate
In total, about 14,000 different proteins passed the filter criteria combined for all six samples
(Tables S2 and S3).
The PSM (peptide spectrum match), peptide, and protein/protein group identification rates of FF
samples were approx. 13%, 15%, and 17% higher, respectively, compared with RL samples. About 25%
more unique proteins were identified in replicates of FF samples (Figure 1a–c).
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When counting only bacterial proteins that were found in at least two replicates, 20% more could
be found in FF. The overlap amounted to about 60% of the total number of proteins found in at least
two replicates for FF, and 70% for RL (Figure 1d).
Of all bacterial proteins identified, about 2000 were significantly differentially abundant, around
1300 of these had a higher abundance in FF (Table S4).
3.2. Metaproteomics-Based Taxonomic Profiles Differed Significantly between Storage Conditions
At the class level, the taxonomic origin of proteins was vastly different between the tested
conditions. About 35% of the assignable proteins that were significantly more abundant in FF belonged
to Actinobacteria, whereas in RL, Actinobacteria only made up approx. 0.2%. The opposite was observed
for the proportions of Bacteroidia. They made up about 30% of the significantly more abundant proteins
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of RL and only 1.5% of the significantly more abundant proteins in FF. Similarly, Proteobacteria and
Negativicutes were almost nonexistent in FF, but made up approx. 5% and 10% in RL, respectively.
The majority of significantly higher abundant proteins comprised clostridial proteins, with approx.
65% and 55%, respectively (Figure 2a).
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proteins at class level; (b): Functional analysis of proteins which were mappable to the KEGG Orthology
database and that had a functional annotation assigned. Contains only protein identifications that
occurred in at least two of three replicates (normalized NSAFs, significance testing: Fold change ≥ 1.5,
t-test, Benjamini–Hochberg-corrected, p < 0.05) and that could be annotated. FF: flash frozen;
RL: RNAlater-treated.
Functional annotation using the KEGG Orthology (KO) database also revealed small differences
betwee FF and RL samples. I both conditions, proteins assigned to metabolism and processing of
g netic information posses ed the largest share of proteins i ificantly more abundant. The share
of metabolis -related proteins was 10% high r in FF, whereas the proportion of proteins related to
processing of gen tic information was about 6% higher in RL. Less than 10% of pr teins were attributed
to cellular processes and processing of envir nmental info mation, respectively. Both categorie mad
up a slightly larger share in RL. The percentage of proteins assigned to organismal systems and human
dis ase were below 1% for both conditions, respectively (Figure 2b).
Overall the fu ction l diff nces ere n t as disti ct as the taxonomic ones.
3.3. Integration of Metagenomics and Metaproteomics Data
The ratios of the shares of classes between FF and RL metagenomics and metaproteomics
approaches were similar (Figure 3, T bl S5). In the metagenomic analysis, Actinobacteria re es nted a
much larger proportion for FF, whereas Bacteroidia, B -, Deltaproteobacteria, a d Negativicut were
more abundant in RL. The ratios between FF and RL wer similar for Actinobacteria, Bacteroidia,
and Clostri i , however, Actinobacteria and Bacteroidia were more bundan in metagenomics an lysis,
and Clostridia were more a undant in metaproteomics analysis.
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Figure 3. Metaproteomic and metagenomic proportions of identifications at class level (Tables S3, S5 and
S6). For the metaproteomics data, proteins that could not be assigned using the bacterial annotations
(Table S1) were excluded and made up about 52% and 49% for flash frozen and RNAlater-treated
samples, respectively. (g_FF: metagenomic analysis for flash frozen, g_RL: metagenomic analysis for
RNAlater, p_FF: metaproteomic analysis for flash frozen, p_RL: metaproteomic analysis for RNAlater).
Actinobacteria, while having the same ratio between FF and RL on both omics levels (Table S5),
made up a much larger share in the metagenomics analysis. Bacteroidia were much more abundant
in the metagenomics analysis, whereas Clostridia made up a larger share in metaproteomics.
Gammaproteobacteria were only detected in low amounts with metagenomics, Erysipelotrichi in low
amounts on both omics levels. In conclusion, the taxonomic profiles of the metaproteomics and
metagenomics analyses concur in most cases.
3.4. Annotation of Identified Proteins Using Prophane
Taxonomic annotati n of proteins w th Propha e using DIAMOND BLAST [59] against the
NCBI RefSeq nonredundant database [60] produced similar results compared with processing with
the metagenomics-derived annotation (Figure S1K). Flash frozen samples contain d almost 20%
Actinobacteria, while they made up less than 2% in RNAlate -treated sampl s. Coriobacteriia represented
about 4% in FF and wer almost not detected in RL. It has t be noted that C riobac riia form one class
with Actinobacteria in the microbial annotations (Table S1) and are thus not detected separately during
annotation with that resource (Fi ure 3, Tables S3 and S5; [46]). Proportions of Bacteroidia were 17% for
FF and around 40% or RL. An logo s to he metagenomics-based annotation, Negativicutes and the
different classes of Proteobacteria were more abundant in RL, whereas Clostridia made up about 50% in
both storage conditions. Approximately 3% and 4% f ba terial proteins f r FF nd RL, respectively,
could not be annotated by Prophane.
Functional annotation using the EggNOG [61] database showed both storage conditions to be
similar. The share of proteins attributed to a metabolic function was 5% higher in FF, while ones
assigned to cellular processes and signaling, as well as information storage and processing made up
around 2% more in RL. To roughly 43% of proteins, no function or only a poor characterization could
be assigned in both conditions (Figure S2K).
4. Discussion
The higher identification rates of FF and the large proportion of proteins identified exclusively in FF
or RL indicate a strong impact of sampling and initial storage conditions on the information content of the
sa ple (Figure 1). The alikeness of the functional profiles of flash frozen and RNAlater-treated samples
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(Figure 2b and Figure S2K), as well as the similarity of taxonomic profiles between metagenomics and
metaproteomics, might hint to a difference in effect on overall cell preservation and/or proliferation
(Figure 3). It may, for example, be possible that some bacteria overgrow others during refrigeration in
the RNAlater-treated samples, or that immersion in RNAlater results in osmotic shock, thus distorting
the original composition of the sample. Differences between the taxonomic composition after annotation
with metagenomics-based data and Prophane are likely ascribable to the much larger amount of
unannotated proteins using the metagenomics-based approach, shifting the proportions.
The small differences of functional profiles could be attributed to the differential preservation of
taxonomic groups that have different physiological capabilities. A direct effect of the treatments on
specific (functional) groups seems unlikely.
The higher identification rate of flash frozen samples could be attributable to superior
conservational effect (Figure 1a–c). Results of Fouhy et al., for example, suggest that flash freezing
keeps the taxonomic profile similar to that of samples that are directly analyzed [35], and it is therefore
considered the gold-standard approach.
There are already various published metagenomics studies available discussing effects of different
storage conditions [35,40,62–66], some of them showing, to an extent, similar results [62,64,65].
Several of these studies reported an increase in share of Gram negatives in RNAlater-stored samples
compared with flash frozen ones, which is in agreement with this studies results (Figure 2a) [64,65].
Choo et al. observed significantly fewer Actinobacteria in RNAlater-treated samples compared with
frozen ones as well, even though the methodology did differ [64]. Neither RNAlaterICE nor flash
freezing was applied. Dominianni et al. observed similar microbial community compositions to the
ones observed in this study in samples of one of the study subjects, although overall there were no
significant differences [62].
Others observed no significant changes, but also detected almost no Actinobacteria, which this study
found to be significantly less abundant in RNAlater-stored samples (Figure 2a) [35,63,66]. Hale et al.
studied samples of a different species and their methodology differed in several key parameters, such as
storage of RNAlater-immersed samples at room temperature for extended amounts of time and absence
of RNAlaterICE from the samples stored at −80 ◦C [63]. These factors might well explain the distinctly
different results. Fouhy et al. [35] and Guo et al. [66] serve as examples of studies using human faecal
samples but detecting almost no Actinobacteria. The reason for this remains unclear, as both studies do
not seem to share more characteristics of methodology and/or sample origin with each other than with
other similar studies. Although, in the case of the Guo et al. study, the reason might be that faecal
samples from infants were employed [66]. Voigt et al. [40] found no significant differences in taxonomic
composition between RNAlater-stored and frozen samples as well. Again, the experimental setup
differed significantly, with samples stored at −20 ◦C initially, requiring transport to the laboratory,
and frozen samples not being flash frozen.
Taken together, this set of disagreeing and agreeing studies with varying degrees of similarity in
methodology shows clearly why a standardized sample storage/processing approach might be crucial
to achieve more reproducible results in the field of human microbiome omics studies.
The cause for the significantly lesser abundance of Actinobacteria and the increased share of Gram
negatives in RNAlater-stored samples in this study could be a lesser tolerance of Gram negatives
to the flash freezing process, differences in the ability of both methods to preserve oxygen-sensitive
(anaerobic) bacteria and/or growth (in RNAlater-treated samples). No obvious difference could be
detected in the amount of Clostridia, which made up a large portion of overall detected, but also
significantly differentially abundant proteins on class level. As there is quite a lot of discussion about
the phylogenetically most correct assignment of members of the class Clostridia, and as they are a
phenotypically very diverse group [67,68], it is possible that the proteins significantly more abundant
in one or the other condition belonging to Clostridia are ones of sub-groups, with properties that
are, for example, preserved better in those conditions. In fact, significantly differentially abundant
proteins for the clostridial genera Ruminococcus, Blautia, and Clostridium were only found in FF,
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whereas Pseudoflavonibacter proteins were only found in RL. Additionally, Dorea was much more
abundant in FF, and Oscillibacter as well as Faecalibacterium were much more abundant in RL.
The central question regarding this study, as well as previous ones, is how relevant these
observations are for a scientist planning or evaluating an “omics” experiment. Is initial sample storage
something that introduces minor variations in information contained in a (stool) sample and that
could probably be rendered irrelevant by often-observed large interindividual variability of the gut
microbiome [40,66,69]? To resolve this, further investigations into the reaction of different members of a
sample’s microbiota to RNAlater, RNAlaterICE, and the flash freezing process might be necessary and,
once understood, will then allow to recognize conditions which modulate the microbial community
structure in a certain way. This would need to be performed with sufficiently large sample sizes to take
differences in the microbiota composition because of interindividual variation into account and enable
researchers to separate effects caused by storage conditions or inherent variability.
Based on the distinct difference of results between sampling and storage conditions obtained in
this study, it seems clear that proper and consistent storage of samples is essential for the ability to
obtain high-quality (metaproteomics) data from environmental samples such as human stool. One has
to keep in mind as well, that lacking other metaproteomics experiments to compare to, almost all of
the studies cited here use metagenomics in one form or the other. To the authors best knowledge
this is the first study combining metagenomics and metaproteomics to study the effects of storage
conditions on human stool samples. It suggests that great care should be taken in the initial processing
of microbiome samples for a multi-omics or metaproteomics experiment.
5. Conclusions
Depending on the processing method chosen for initial storage, the information content of samples
for metaproteomics analysis might vary considerably. These findings could prove especially useful
not only for future (meta) proteomics studies, but also the rapidly developing field of integrated
multi-omics, as it indicates that initial storage conditions should be chosen that permit an analysis of
all biomolecules of interest. Finally, flash freezing, storage at −80 ◦C, and handling without thawing is,
as reported numerous times, the gold standard to maximize the preservation of a sample.
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